CLINICAL_TRIALS
trial_result
· 2016-01-26
Clinical Trial Update: Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) [Phase 3]
Summary
Phase 3 clinical trial update evaluating lipid efficacy and safety in participants with mixed hyperlipidemia; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Mixed Hyperlipidemia | Phase 3 | Status: COMPLETED | Results posted: 2016-01-26